INGN — Stock Film
STOCK FILMSCENE 1/11INGN · $6.66
Stock Expert AI presents
INGN
Inogen, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Inogen, Inc. A quick introduction.

On the stock market since 2014, it operates in the world of health and science. It has 753 employees. Now — the numbers.

on the stock market since 2014
753 employees
$180.3M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.1.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

In the vault right now:
$0
DEBT: $17.5M
At this pace, that money lasts about 5.3 years.

Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.

What executives did with their own stock over the last 12 months:
40 buy32 sell

Executives buying with their own money is usually read as confidence in the company’s future.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
74
strong

Clearly above the class average — a step short of the very top.

FINANCIAL STRENGTH
27
very weak

Clearly below the class average.

VALUATION
73
strong

Clearly above the class average — a step short of the very top.

GROWTH
20
very weak

Clearly below the class average.

PRICE MOMENTUM
48
weak

Clearly below the class average.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 5 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking8/10
A strong cash pile8/10
Few are betting against it10/10
WEAK SPOTS
The stock has lost its spark3/10
Growth has stalled4/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 92% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
Sales are holding up

The company sells $348.7M a year; the problem isn’t sales — it’s costs running above that number.

2
THE BRIGHT SIDE · 2/3
Strong cash, light debt

There is $119.6M in the vault; even if every debt were paid off, $102.1M would remain.

3
THE BRIGHT SIDE · 3/3
Delivers on expectations

It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.

1
THE RISKS · 1/3
Running at a loss

A loss of $22.7M against $348.7M in annual sales.

2
THE RISKS · 2/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 20/100.

3
THE RISKS · 3/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 27/100.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, INGN sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: INGN is a small company that closed last year at a loss. The road back to profit runs through spending discipline.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film